nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Disulfiram—alcohol dependence	0.164	0.584	CbGbCtD
Tadalafil—CYP3A4—Citalopram—alcohol dependence	0.117	0.416	CbGbCtD
Tadalafil—PDE11A—endocrine gland—alcohol dependence	0.00899	0.112	CbGeAlD
Tadalafil—PDE11A—testis—alcohol dependence	0.00857	0.106	CbGeAlD
Tadalafil—PDE11A—liver—alcohol dependence	0.0081	0.101	CbGeAlD
Tadalafil—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00658	0.0718	CbGpPWpGaD
Tadalafil—PDE11A—brain—alcohol dependence	0.00643	0.0799	CbGeAlD
Tadalafil—PDE5A—forebrain—alcohol dependence	0.0059	0.0732	CbGeAlD
Tadalafil—PDE5A—cardiovascular system—alcohol dependence	0.00499	0.0619	CbGeAlD
Tadalafil—PDE5A—gonad—alcohol dependence	0.00453	0.0562	CbGeAlD
Tadalafil—PDE11A—G alpha (s) signalling events—CRHR1—alcohol dependence	0.00445	0.0485	CbGpPWpGaD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00422	0.046	CbGpPWpGaD
Tadalafil—PDE5A—digestive system—alcohol dependence	0.00414	0.0514	CbGeAlD
Tadalafil—PDE5A—blood—alcohol dependence	0.00394	0.049	CbGeAlD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00349	0.0381	CbGpPWpGaD
Tadalafil—PDE5A—endocrine gland—alcohol dependence	0.00342	0.0425	CbGeAlD
Tadalafil—PDE11A—G alpha (s) signalling events—CRH—alcohol dependence	0.00341	0.0372	CbGpPWpGaD
Tadalafil—PDE5A—testis—alcohol dependence	0.00326	0.0405	CbGeAlD
Tadalafil—PDE5A—nervous system—alcohol dependence	0.0032	0.0398	CbGeAlD
Tadalafil—PDE5A—central nervous system—alcohol dependence	0.00308	0.0383	CbGeAlD
Tadalafil—PDE5A—cerebellum—alcohol dependence	0.00301	0.0374	CbGeAlD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00297	0.0324	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—HTR7—alcohol dependence	0.00278	0.0303	CbGpPWpGaD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00253	0.0275	CbGpPWpGaD
Tadalafil—PDE5A—brain—alcohol dependence	0.00245	0.0304	CbGeAlD
Tadalafil—Migraine—Naltrexone—alcohol dependence	0.0024	0.0044	CcSEcCtD
Tadalafil—Liver function test abnormal—Acamprosate—alcohol dependence	0.00238	0.00436	CcSEcCtD
Tadalafil—Musculoskeletal stiffness—Citalopram—alcohol dependence	0.00238	0.00435	CcSEcCtD
Tadalafil—Rectal haemorrhage—Citalopram—alcohol dependence	0.00236	0.00432	CcSEcCtD
Tadalafil—Bone disorder—Citalopram—alcohol dependence	0.00236	0.00432	CcSEcCtD
Tadalafil—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.00236	0.00432	CcSEcCtD
Tadalafil—Face oedema—Naltrexone—alcohol dependence	0.00236	0.00432	CcSEcCtD
Tadalafil—Orthostatic hypotension—Acamprosate—alcohol dependence	0.00236	0.00432	CcSEcCtD
Tadalafil—PDE11A—G alpha (s) signalling events—AVP—alcohol dependence	0.00234	0.0255	CbGpPWpGaD
Tadalafil—Breast disorder—Acamprosate—alcohol dependence	0.00233	0.00427	CcSEcCtD
Tadalafil—Paraesthesia—Disulfiram—alcohol dependence	0.00231	0.00423	CcSEcCtD
Tadalafil—Somnolence—Disulfiram—alcohol dependence	0.00229	0.00419	CcSEcCtD
Tadalafil—Gastritis—Acamprosate—alcohol dependence	0.00229	0.00418	CcSEcCtD
Tadalafil—Influenza—Acamprosate—alcohol dependence	0.00223	0.00408	CcSEcCtD
Tadalafil—Dysphagia—Acamprosate—alcohol dependence	0.00223	0.00408	CcSEcCtD
Tadalafil—Abdominal pain upper—Naltrexone—alcohol dependence	0.00223	0.00408	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00222	0.0242	CbGpPWpGaD
Tadalafil—Fatigue—Disulfiram—alcohol dependence	0.00222	0.00406	CcSEcCtD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00221	0.0241	CbGpPWpGaD
Tadalafil—Pain—Disulfiram—alcohol dependence	0.0022	0.00403	CcSEcCtD
Tadalafil—Nasopharyngitis—Naltrexone—alcohol dependence	0.00218	0.004	CcSEcCtD
Tadalafil—Angina pectoris—Acamprosate—alcohol dependence	0.00217	0.00398	CcSEcCtD
Tadalafil—Neck pain—Citalopram—alcohol dependence	0.00216	0.00395	CcSEcCtD
Tadalafil—Bronchitis—Acamprosate—alcohol dependence	0.00215	0.00393	CcSEcCtD
Tadalafil—Influenza—Naltrexone—alcohol dependence	0.00211	0.00386	CcSEcCtD
Tadalafil—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00211	0.023	CbGpPWpGaD
Tadalafil—Angina pectoris—Naltrexone—alcohol dependence	0.00206	0.00376	CcSEcCtD
Tadalafil—Bronchitis—Naltrexone—alcohol dependence	0.00203	0.00372	CcSEcCtD
Tadalafil—Abdominal discomfort—Naltrexone—alcohol dependence	0.00202	0.0037	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00196	0.00359	CcSEcCtD
Tadalafil—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00196	0.00359	CcSEcCtD
Tadalafil—Myocardial infarction—Acamprosate—alcohol dependence	0.00195	0.00357	CcSEcCtD
Tadalafil—Oesophagitis—Citalopram—alcohol dependence	0.00195	0.00357	CcSEcCtD
Tadalafil—Urinary tract infection—Acamprosate—alcohol dependence	0.00193	0.00354	CcSEcCtD
Tadalafil—Sweating—Acamprosate—alcohol dependence	0.00191	0.00349	CcSEcCtD
Tadalafil—Haematuria—Acamprosate—alcohol dependence	0.0019	0.00347	CcSEcCtD
Tadalafil—Infestation NOS—Naltrexone—alcohol dependence	0.00188	0.00345	CcSEcCtD
Tadalafil—Infestation—Naltrexone—alcohol dependence	0.00188	0.00345	CcSEcCtD
Tadalafil—Epistaxis—Acamprosate—alcohol dependence	0.00188	0.00343	CcSEcCtD
Tadalafil—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00186	0.0034	CcSEcCtD
Tadalafil—Asthenia—Disulfiram—alcohol dependence	0.00185	0.00338	CcSEcCtD
Tadalafil—Myocardial infarction—Naltrexone—alcohol dependence	0.00185	0.00338	CcSEcCtD
Tadalafil—Urinary tract infection—Naltrexone—alcohol dependence	0.00183	0.00335	CcSEcCtD
Tadalafil—Conjunctivitis—Naltrexone—alcohol dependence	0.00183	0.00335	CcSEcCtD
Tadalafil—Haemoglobin—Acamprosate—alcohol dependence	0.0018	0.00329	CcSEcCtD
Tadalafil—Rhinitis—Acamprosate—alcohol dependence	0.00179	0.00328	CcSEcCtD
Tadalafil—Haemorrhage—Acamprosate—alcohol dependence	0.00179	0.00327	CcSEcCtD
Tadalafil—Hypoaesthesia—Acamprosate—alcohol dependence	0.00178	0.00325	CcSEcCtD
Tadalafil—Epistaxis—Naltrexone—alcohol dependence	0.00178	0.00325	CcSEcCtD
Tadalafil—Pharyngitis—Acamprosate—alcohol dependence	0.00177	0.00324	CcSEcCtD
Tadalafil—Oedema peripheral—Acamprosate—alcohol dependence	0.00176	0.00322	CcSEcCtD
Tadalafil—Gastroenteritis—Citalopram—alcohol dependence	0.00175	0.0032	CcSEcCtD
Tadalafil—Deafness—Citalopram—alcohol dependence	0.00173	0.00317	CcSEcCtD
Tadalafil—Eye pain—Citalopram—alcohol dependence	0.00171	0.00314	CcSEcCtD
Tadalafil—Dizziness—Disulfiram—alcohol dependence	0.0017	0.00312	CcSEcCtD
Tadalafil—Nasal congestion—Citalopram—alcohol dependence	0.0017	0.00311	CcSEcCtD
Tadalafil—Pharyngitis—Naltrexone—alcohol dependence	0.00168	0.00307	CcSEcCtD
Tadalafil—Tinnitus—Acamprosate—alcohol dependence	0.00167	0.00305	CcSEcCtD
Tadalafil—Connective tissue disorder—Naltrexone—alcohol dependence	0.00166	0.00304	CcSEcCtD
Tadalafil—Hot flush—Citalopram—alcohol dependence	0.00165	0.00303	CcSEcCtD
Tadalafil—Amnesia—Citalopram—alcohol dependence	0.00165	0.00301	CcSEcCtD
Tadalafil—Menopausal symptoms—Citalopram—alcohol dependence	0.00164	0.003	CcSEcCtD
Tadalafil—Rash—Disulfiram—alcohol dependence	0.00162	0.00297	CcSEcCtD
Tadalafil—Headache—Disulfiram—alcohol dependence	0.00161	0.00295	CcSEcCtD
Tadalafil—Immune system disorder—Acamprosate—alcohol dependence	0.00161	0.00295	CcSEcCtD
Tadalafil—Cerebrovascular accident—Citalopram—alcohol dependence	0.00158	0.00289	CcSEcCtD
Tadalafil—Eye disorder—Naltrexone—alcohol dependence	0.00158	0.00289	CcSEcCtD
Tadalafil—Tinnitus—Naltrexone—alcohol dependence	0.00158	0.00288	CcSEcCtD
Tadalafil—Cardiac disorder—Naltrexone—alcohol dependence	0.00157	0.00287	CcSEcCtD
Tadalafil—Mental disorder—Acamprosate—alcohol dependence	0.00156	0.00286	CcSEcCtD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00156	0.017	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—POMC—alcohol dependence	0.00155	0.0169	CbGpPWpGaD
Tadalafil—Pain in extremity—Citalopram—alcohol dependence	0.00155	0.00283	CcSEcCtD
Tadalafil—Angiopathy—Naltrexone—alcohol dependence	0.00153	0.00281	CcSEcCtD
Tadalafil—Immune system disorder—Naltrexone—alcohol dependence	0.00153	0.00279	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—OPRK1—alcohol dependence	0.00152	0.0166	CbGpPWpGaD
Tadalafil—Migraine—Citalopram—alcohol dependence	0.00152	0.00279	CcSEcCtD
Tadalafil—Mediastinal disorder—Naltrexone—alcohol dependence	0.00152	0.00279	CcSEcCtD
Tadalafil—Back pain—Acamprosate—alcohol dependence	0.0015	0.00275	CcSEcCtD
Tadalafil—Muscle spasms—Acamprosate—alcohol dependence	0.0015	0.00274	CcSEcCtD
Tadalafil—Face oedema—Citalopram—alcohol dependence	0.00149	0.00273	CcSEcCtD
Tadalafil—Mental disorder—Naltrexone—alcohol dependence	0.00148	0.00271	CcSEcCtD
Tadalafil—Liver function test abnormal—Citalopram—alcohol dependence	0.00143	0.00262	CcSEcCtD
Tadalafil—Back pain—Naltrexone—alcohol dependence	0.00142	0.0026	CcSEcCtD
Tadalafil—Angioedema—Acamprosate—alcohol dependence	0.00142	0.0026	CcSEcCtD
Tadalafil—Muscle spasms—Naltrexone—alcohol dependence	0.00141	0.00259	CcSEcCtD
Tadalafil—Abdominal pain upper—Citalopram—alcohol dependence	0.00141	0.00259	CcSEcCtD
Tadalafil—Orthostatic hypotension—Citalopram—alcohol dependence	0.00141	0.00259	CcSEcCtD
Tadalafil—Breast disorder—Citalopram—alcohol dependence	0.0014	0.00256	CcSEcCtD
Tadalafil—Vertigo—Acamprosate—alcohol dependence	0.0014	0.00256	CcSEcCtD
Tadalafil—Syncope—Acamprosate—alcohol dependence	0.00139	0.00255	CcSEcCtD
Tadalafil—Vision blurred—Naltrexone—alcohol dependence	0.00139	0.00254	CcSEcCtD
Tadalafil—Nasopharyngitis—Citalopram—alcohol dependence	0.00138	0.00253	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—OPRK1—alcohol dependence	0.00138	0.0151	CbGpPWpGaD
Tadalafil—Palpitations—Acamprosate—alcohol dependence	0.00137	0.00251	CcSEcCtD
Tadalafil—Gastritis—Citalopram—alcohol dependence	0.00137	0.00251	CcSEcCtD
Tadalafil—Loss of consciousness—Acamprosate—alcohol dependence	0.00137	0.0025	CcSEcCtD
Tadalafil—Cough—Acamprosate—alcohol dependence	0.00136	0.00248	CcSEcCtD
Tadalafil—Convulsion—Acamprosate—alcohol dependence	0.00135	0.00247	CcSEcCtD
Tadalafil—Angioedema—Naltrexone—alcohol dependence	0.00134	0.00246	CcSEcCtD
Tadalafil—Hypertension—Acamprosate—alcohol dependence	0.00134	0.00246	CcSEcCtD
Tadalafil—Influenza—Citalopram—alcohol dependence	0.00134	0.00245	CcSEcCtD
Tadalafil—Dysphagia—Citalopram—alcohol dependence	0.00134	0.00245	CcSEcCtD
Tadalafil—Myalgia—Acamprosate—alcohol dependence	0.00132	0.00242	CcSEcCtD
Tadalafil—Chest pain—Acamprosate—alcohol dependence	0.00132	0.00242	CcSEcCtD
Tadalafil—Arthralgia—Acamprosate—alcohol dependence	0.00132	0.00242	CcSEcCtD
Tadalafil—Syncope—Naltrexone—alcohol dependence	0.00132	0.00241	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00131	0.00241	CcSEcCtD
Tadalafil—Discomfort—Acamprosate—alcohol dependence	0.00131	0.00239	CcSEcCtD
Tadalafil—Angina pectoris—Citalopram—alcohol dependence	0.0013	0.00238	CcSEcCtD
Tadalafil—Palpitations—Naltrexone—alcohol dependence	0.0013	0.00238	CcSEcCtD
Tadalafil—Dry mouth—Acamprosate—alcohol dependence	0.00129	0.00237	CcSEcCtD
Tadalafil—Loss of consciousness—Naltrexone—alcohol dependence	0.00129	0.00237	CcSEcCtD
Tadalafil—CYP3A4—digestive system—alcohol dependence	0.00129	0.016	CbGeAlD
Tadalafil—Bronchitis—Citalopram—alcohol dependence	0.00129	0.00235	CcSEcCtD
Tadalafil—Cough—Naltrexone—alcohol dependence	0.00128	0.00235	CcSEcCtD
Tadalafil—Abdominal discomfort—Citalopram—alcohol dependence	0.00128	0.00235	CcSEcCtD
Tadalafil—Convulsion—Naltrexone—alcohol dependence	0.00127	0.00233	CcSEcCtD
Tadalafil—Hypertension—Naltrexone—alcohol dependence	0.00127	0.00232	CcSEcCtD
Tadalafil—Infection—Acamprosate—alcohol dependence	0.00126	0.00231	CcSEcCtD
Tadalafil—Arthralgia—Naltrexone—alcohol dependence	0.00125	0.00229	CcSEcCtD
Tadalafil—Myalgia—Naltrexone—alcohol dependence	0.00125	0.00229	CcSEcCtD
Tadalafil—Chest pain—Naltrexone—alcohol dependence	0.00125	0.00229	CcSEcCtD
Tadalafil—Shock—Acamprosate—alcohol dependence	0.00125	0.00228	CcSEcCtD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00125	0.0136	CbGpPWpGaD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00124	0.00228	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00124	0.00228	CcSEcCtD
Tadalafil—Tachycardia—Acamprosate—alcohol dependence	0.00124	0.00227	CcSEcCtD
Tadalafil—Discomfort—Naltrexone—alcohol dependence	0.00124	0.00226	CcSEcCtD
Tadalafil—Skin disorder—Acamprosate—alcohol dependence	0.00123	0.00226	CcSEcCtD
Tadalafil—CYP3A4—blood—alcohol dependence	0.00123	0.0153	CbGeAlD
Tadalafil—Hyperhidrosis—Acamprosate—alcohol dependence	0.00123	0.00225	CcSEcCtD
Tadalafil—Dry mouth—Naltrexone—alcohol dependence	0.00122	0.00224	CcSEcCtD
Tadalafil—Oedema—Naltrexone—alcohol dependence	0.0012	0.0022	CcSEcCtD
Tadalafil—Infection—Naltrexone—alcohol dependence	0.00119	0.00218	CcSEcCtD
Tadalafil—Infestation NOS—Citalopram—alcohol dependence	0.00119	0.00218	CcSEcCtD
Tadalafil—Infestation—Citalopram—alcohol dependence	0.00119	0.00218	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00119	0.0129	CbGpPWpGaD
Tadalafil—Hypotension—Acamprosate—alcohol dependence	0.00119	0.00217	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.00118	0.00216	CcSEcCtD
Tadalafil—Shock—Naltrexone—alcohol dependence	0.00118	0.00216	CcSEcCtD
Tadalafil—Nervous system disorder—Naltrexone—alcohol dependence	0.00118	0.00215	CcSEcCtD
Tadalafil—Acute coronary syndrome—Citalopram—alcohol dependence	0.00118	0.00215	CcSEcCtD
Tadalafil—Tachycardia—Naltrexone—alcohol dependence	0.00117	0.00214	CcSEcCtD
Tadalafil—Myocardial infarction—Citalopram—alcohol dependence	0.00117	0.00214	CcSEcCtD
Tadalafil—Skin disorder—Naltrexone—alcohol dependence	0.00117	0.00213	CcSEcCtD
Tadalafil—Hyperhidrosis—Naltrexone—alcohol dependence	0.00116	0.00212	CcSEcCtD
Tadalafil—Urinary tract infection—Citalopram—alcohol dependence	0.00116	0.00212	CcSEcCtD
Tadalafil—Conjunctivitis—Citalopram—alcohol dependence	0.00116	0.00212	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00116	0.00212	CcSEcCtD
Tadalafil—Insomnia—Acamprosate—alcohol dependence	0.00115	0.0021	CcSEcCtD
Tadalafil—Sweating—Citalopram—alcohol dependence	0.00114	0.00209	CcSEcCtD
Tadalafil—Paraesthesia—Acamprosate—alcohol dependence	0.00114	0.00209	CcSEcCtD
Tadalafil—Haematuria—Citalopram—alcohol dependence	0.00114	0.00208	CcSEcCtD
Tadalafil—Dyspnoea—Acamprosate—alcohol dependence	0.00113	0.00207	CcSEcCtD
Tadalafil—Somnolence—Acamprosate—alcohol dependence	0.00113	0.00206	CcSEcCtD
Tadalafil—Epistaxis—Citalopram—alcohol dependence	0.00113	0.00206	CcSEcCtD
Tadalafil—Dyspepsia—Acamprosate—alcohol dependence	0.00112	0.00204	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.0011	0.002	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00109	0.002	CcSEcCtD
Tadalafil—Insomnia—Naltrexone—alcohol dependence	0.00109	0.00199	CcSEcCtD
Tadalafil—Constipation—Acamprosate—alcohol dependence	0.00109	0.00199	CcSEcCtD
Tadalafil—Pain—Acamprosate—alcohol dependence	0.00109	0.00199	CcSEcCtD
Tadalafil—Paraesthesia—Naltrexone—alcohol dependence	0.00108	0.00197	CcSEcCtD
Tadalafil—Haemoglobin—Citalopram—alcohol dependence	0.00108	0.00197	CcSEcCtD
Tadalafil—Rhinitis—Citalopram—alcohol dependence	0.00107	0.00196	CcSEcCtD
Tadalafil—Haemorrhage—Citalopram—alcohol dependence	0.00107	0.00196	CcSEcCtD
Tadalafil—Dyspnoea—Naltrexone—alcohol dependence	0.00107	0.00196	CcSEcCtD
Tadalafil—Somnolence—Naltrexone—alcohol dependence	0.00107	0.00195	CcSEcCtD
Tadalafil—CYP3A4—endocrine gland—alcohol dependence	0.00107	0.0132	CbGeAlD
Tadalafil—Hypoaesthesia—Citalopram—alcohol dependence	0.00107	0.00195	CcSEcCtD
Tadalafil—Pharyngitis—Citalopram—alcohol dependence	0.00106	0.00194	CcSEcCtD
Tadalafil—Urinary tract disorder—Citalopram—alcohol dependence	0.00106	0.00194	CcSEcCtD
Tadalafil—Oedema peripheral—Citalopram—alcohol dependence	0.00105	0.00193	CcSEcCtD
Tadalafil—Connective tissue disorder—Citalopram—alcohol dependence	0.00105	0.00193	CcSEcCtD
Tadalafil—Urethral disorder—Citalopram—alcohol dependence	0.00105	0.00192	CcSEcCtD
Tadalafil—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.00104	0.0114	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00104	0.0019	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00104	0.0019	CcSEcCtD
Tadalafil—Fatigue—Naltrexone—alcohol dependence	0.00104	0.00189	CcSEcCtD
Tadalafil—Pain—Naltrexone—alcohol dependence	0.00103	0.00188	CcSEcCtD
Tadalafil—Constipation—Naltrexone—alcohol dependence	0.00103	0.00188	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—OPRD1—alcohol dependence	0.00102	0.0112	CbGpPWpGaD
Tadalafil—Erythema multiforme—Citalopram—alcohol dependence	0.00101	0.00185	CcSEcCtD
Tadalafil—Urticaria—Acamprosate—alcohol dependence	0.00101	0.00184	CcSEcCtD
Tadalafil—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.001	0.0109	CbGpPWpGaD
Tadalafil—Abdominal pain—Acamprosate—alcohol dependence	0.001	0.00184	CcSEcCtD
Tadalafil—Eye disorder—Citalopram—alcohol dependence	0.001	0.00183	CcSEcCtD
Tadalafil—Tinnitus—Citalopram—alcohol dependence	0.000998	0.00183	CcSEcCtD
Tadalafil—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000998	0.0109	CbGpPWpGaD
Tadalafil—CYP3A4—nervous system—alcohol dependence	0.000998	0.0124	CbGeAlD
Tadalafil—Cardiac disorder—Citalopram—alcohol dependence	0.000994	0.00182	CcSEcCtD
Tadalafil—Flushing—Citalopram—alcohol dependence	0.000994	0.00182	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000984	0.0107	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000982	0.0018	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—PDYN—alcohol dependence	0.000982	0.0107	CbGpPWpGaD
Tadalafil—Angiopathy—Citalopram—alcohol dependence	0.000972	0.00178	CcSEcCtD
Tadalafil—Immune system disorder—Citalopram—alcohol dependence	0.000967	0.00177	CcSEcCtD
Tadalafil—Mediastinal disorder—Citalopram—alcohol dependence	0.000965	0.00177	CcSEcCtD
Tadalafil—CYP3A4—liver—alcohol dependence	0.000961	0.0119	CbGeAlD
Tadalafil—CYP3A4—central nervous system—alcohol dependence	0.000961	0.0119	CbGeAlD
Tadalafil—Urticaria—Naltrexone—alcohol dependence	0.000954	0.00175	CcSEcCtD
Tadalafil—Abdominal pain—Naltrexone—alcohol dependence	0.000949	0.00174	CcSEcCtD
Tadalafil—Mental disorder—Citalopram—alcohol dependence	0.000938	0.00172	CcSEcCtD
Tadalafil—Hypersensitivity—Acamprosate—alcohol dependence	0.000935	0.00171	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—OPRD1—alcohol dependence	0.00093	0.0101	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CRHR1—alcohol dependence	0.000913	0.00995	CbGpPWpGaD
Tadalafil—Asthenia—Acamprosate—alcohol dependence	0.000911	0.00167	CcSEcCtD
Tadalafil—Back pain—Citalopram—alcohol dependence	0.000902	0.00165	CcSEcCtD
Tadalafil—Pruritus—Acamprosate—alcohol dependence	0.000898	0.00164	CcSEcCtD
Tadalafil—Muscle spasms—Citalopram—alcohol dependence	0.000896	0.00164	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—PDYN—alcohol dependence	0.000892	0.00972	CbGpPWpGaD
Tadalafil—Hypersensitivity—Naltrexone—alcohol dependence	0.000885	0.00162	CcSEcCtD
Tadalafil—Vision blurred—Citalopram—alcohol dependence	0.000879	0.00161	CcSEcCtD
Tadalafil—Diarrhoea—Acamprosate—alcohol dependence	0.000868	0.00159	CcSEcCtD
Tadalafil—Asthenia—Naltrexone—alcohol dependence	0.000861	0.00158	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—CHRM2—alcohol dependence	0.000858	0.00935	CbGpPWpGaD
Tadalafil—Angioedema—Citalopram—alcohol dependence	0.000852	0.00156	CcSEcCtD
Tadalafil—Pruritus—Naltrexone—alcohol dependence	0.00085	0.00155	CcSEcCtD
Tadalafil—Dizziness—Acamprosate—alcohol dependence	0.000839	0.00154	CcSEcCtD
Tadalafil—Vertigo—Citalopram—alcohol dependence	0.000838	0.00153	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000837	0.00912	CbGpPWpGaD
Tadalafil—Syncope—Citalopram—alcohol dependence	0.000836	0.00153	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CRHR1—alcohol dependence	0.000829	0.00904	CbGpPWpGaD
Tadalafil—Palpitations—Citalopram—alcohol dependence	0.000824	0.00151	CcSEcCtD
Tadalafil—Diarrhoea—Naltrexone—alcohol dependence	0.000822	0.0015	CcSEcCtD
Tadalafil—Loss of consciousness—Citalopram—alcohol dependence	0.000819	0.0015	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—OPRK1—alcohol dependence	0.000817	0.00891	CbGpPWpGaD
Tadalafil—Cough—Citalopram—alcohol dependence	0.000813	0.00149	CcSEcCtD
Tadalafil—Convulsion—Citalopram—alcohol dependence	0.000808	0.00148	CcSEcCtD
Tadalafil—Vomiting—Acamprosate—alcohol dependence	0.000807	0.00148	CcSEcCtD
Tadalafil—Hypertension—Citalopram—alcohol dependence	0.000805	0.00147	CcSEcCtD
Tadalafil—Rash—Acamprosate—alcohol dependence	0.0008	0.00146	CcSEcCtD
Tadalafil—Dermatitis—Acamprosate—alcohol dependence	0.000799	0.00146	CcSEcCtD
Tadalafil—Headache—Acamprosate—alcohol dependence	0.000795	0.00145	CcSEcCtD
Tadalafil—Dizziness—Naltrexone—alcohol dependence	0.000794	0.00145	CcSEcCtD
Tadalafil—Chest pain—Citalopram—alcohol dependence	0.000794	0.00145	CcSEcCtD
Tadalafil—Arthralgia—Citalopram—alcohol dependence	0.000794	0.00145	CcSEcCtD
Tadalafil—Myalgia—Citalopram—alcohol dependence	0.000794	0.00145	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000789	0.0086	CbGpPWpGaD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000788	0.00144	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—OPRM1—alcohol dependence	0.000788	0.00859	CbGpPWpGaD
Tadalafil—Discomfort—Citalopram—alcohol dependence	0.000784	0.00143	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CHRM2—alcohol dependence	0.000779	0.0085	CbGpPWpGaD
Tadalafil—Dry mouth—Citalopram—alcohol dependence	0.000776	0.00142	CcSEcCtD
Tadalafil—Vomiting—Naltrexone—alcohol dependence	0.000763	0.0014	CcSEcCtD
Tadalafil—Oedema—Citalopram—alcohol dependence	0.000761	0.00139	CcSEcCtD
Tadalafil—Rash—Naltrexone—alcohol dependence	0.000757	0.00139	CcSEcCtD
Tadalafil—Dermatitis—Naltrexone—alcohol dependence	0.000756	0.00138	CcSEcCtD
Tadalafil—Infection—Citalopram—alcohol dependence	0.000756	0.00138	CcSEcCtD
Tadalafil—Nausea—Acamprosate—alcohol dependence	0.000754	0.00138	CcSEcCtD
Tadalafil—Headache—Naltrexone—alcohol dependence	0.000752	0.00138	CcSEcCtD
Tadalafil—Shock—Citalopram—alcohol dependence	0.000748	0.00137	CcSEcCtD
Tadalafil—Nervous system disorder—Citalopram—alcohol dependence	0.000746	0.00137	CcSEcCtD
Tadalafil—Tachycardia—Citalopram—alcohol dependence	0.000743	0.00136	CcSEcCtD
Tadalafil—Skin disorder—Citalopram—alcohol dependence	0.000739	0.00135	CcSEcCtD
Tadalafil—Hyperhidrosis—Citalopram—alcohol dependence	0.000735	0.00135	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—NPY—alcohol dependence	0.000725	0.0079	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—OPRM1—alcohol dependence	0.000716	0.0078	CbGpPWpGaD
Tadalafil—Nausea—Naltrexone—alcohol dependence	0.000713	0.00131	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000711	0.00775	CbGpPWpGaD
Tadalafil—Hypotension—Citalopram—alcohol dependence	0.000711	0.0013	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—HTR1B—alcohol dependence	0.0007	0.00763	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CRH—alcohol dependence	0.0007	0.00763	CbGpPWpGaD
Tadalafil—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000693	0.00127	CcSEcCtD
Tadalafil—Insomnia—Citalopram—alcohol dependence	0.000688	0.00126	CcSEcCtD
Tadalafil—Paraesthesia—Citalopram—alcohol dependence	0.000683	0.00125	CcSEcCtD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000683	0.00744	CbGpPWpGaD
Tadalafil—Dyspnoea—Citalopram—alcohol dependence	0.000678	0.00124	CcSEcCtD
Tadalafil—Somnolence—Citalopram—alcohol dependence	0.000676	0.00124	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.00067	0.00731	CbGpPWpGaD
Tadalafil—Dyspepsia—Citalopram—alcohol dependence	0.00067	0.00123	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—NPY—alcohol dependence	0.000658	0.00718	CbGpPWpGaD
Tadalafil—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000657	0.0012	CcSEcCtD
Tadalafil—Fatigue—Citalopram—alcohol dependence	0.000656	0.0012	CcSEcCtD
Tadalafil—Constipation—Citalopram—alcohol dependence	0.000651	0.00119	CcSEcCtD
Tadalafil—Pain—Citalopram—alcohol dependence	0.000651	0.00119	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CRH—alcohol dependence	0.000635	0.00693	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR1B—alcohol dependence	0.000635	0.00693	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000631	0.00688	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000624	0.0068	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Citalopram—alcohol dependence	0.000622	0.00114	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—DRD4—alcohol dependence	0.000611	0.00667	CbGpPWpGaD
Tadalafil—Urticaria—Citalopram—alcohol dependence	0.000604	0.00111	CcSEcCtD
Tadalafil—Abdominal pain—Citalopram—alcohol dependence	0.000601	0.0011	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—CNR1—alcohol dependence	0.000584	0.00636	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—DRD2—alcohol dependence	0.00057	0.00621	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HTR7—alcohol dependence	0.00057	0.00621	CbGpPWpGaD
Tadalafil—Hypersensitivity—Citalopram—alcohol dependence	0.000561	0.00103	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—DRD4—alcohol dependence	0.000555	0.00605	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—OPRD1—alcohol dependence	0.000549	0.00599	CbGpPWpGaD
Tadalafil—Asthenia—Citalopram—alcohol dependence	0.000546	0.000999	CcSEcCtD
Tadalafil—Pruritus—Citalopram—alcohol dependence	0.000538	0.000985	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000536	0.00584	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CNR1—alcohol dependence	0.00053	0.00578	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PDYN—alcohol dependence	0.000527	0.00574	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000523	0.0057	CbGpPWpGaD
Tadalafil—Diarrhoea—Citalopram—alcohol dependence	0.000521	0.000953	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—HTR7—alcohol dependence	0.000517	0.00564	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—DRD2—alcohol dependence	0.000517	0.00564	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000517	0.00563	CbGpPWpGaD
Tadalafil—Dizziness—Citalopram—alcohol dependence	0.000503	0.000921	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—WASF2—alcohol dependence	0.00049	0.00534	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CRHR1—alcohol dependence	0.00049	0.00534	CbGpPWpGaD
Tadalafil—Vomiting—Citalopram—alcohol dependence	0.000484	0.000885	CcSEcCtD
Tadalafil—Rash—Citalopram—alcohol dependence	0.00048	0.000878	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—AVP—alcohol dependence	0.000479	0.00523	CbGpPWpGaD
Tadalafil—Dermatitis—Citalopram—alcohol dependence	0.000479	0.000877	CcSEcCtD
Tadalafil—Headache—Citalopram—alcohol dependence	0.000477	0.000872	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—WASF1—alcohol dependence	0.000469	0.00512	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CHRM2—alcohol dependence	0.00046	0.00502	CbGpPWpGaD
Tadalafil—Nausea—Citalopram—alcohol dependence	0.000452	0.000827	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000444	0.00484	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000439	0.00479	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AVP—alcohol dependence	0.000435	0.00475	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000433	0.00472	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000428	0.00466	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—OPRM1—alcohol dependence	0.000423	0.00461	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HTR2A—alcohol dependence	0.000399	0.00435	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NPY—alcohol dependence	0.000389	0.00424	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000378	0.00412	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR1B—alcohol dependence	0.000375	0.00409	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CRH—alcohol dependence	0.000375	0.00409	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR2A—alcohol dependence	0.000362	0.00395	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000362	0.00395	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000351	0.00383	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—EP300—alcohol dependence	0.000334	0.00365	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000331	0.00361	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DRD4—alcohol dependence	0.000328	0.00358	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—POMC—alcohol dependence	0.000319	0.00347	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CNR1—alcohol dependence	0.000313	0.00341	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DRD2—alcohol dependence	0.000306	0.00333	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR7—alcohol dependence	0.000306	0.00333	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—EP300—alcohol dependence	0.000298	0.00325	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—POMC—alcohol dependence	0.000289	0.00315	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000289	0.00315	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000275	0.00299	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AVP—alcohol dependence	0.000257	0.0028	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000233	0.00254	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000232	0.00253	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR2A—alcohol dependence	0.000214	0.00233	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000188	0.00205	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000187	0.00203	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000184	0.00201	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000171	0.00187	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—POMC—alcohol dependence	0.000171	0.00186	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000154	0.00167	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EP300—alcohol dependence	0.000113	0.00124	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADH6—alcohol dependence	0.000108	0.00118	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—POMC—alcohol dependence	0.0001	0.00109	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADH1A—alcohol dependence	8.94e-05	0.000974	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADH4—alcohol dependence	7.6e-05	0.000828	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADH7—alcohol dependence	6.46e-05	0.000704	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GGT2—alcohol dependence	6.19e-05	0.000675	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADH1B—alcohol dependence	5.67e-05	0.000618	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MAOB—alcohol dependence	4.69e-05	0.000512	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDH2—alcohol dependence	3.99e-05	0.000435	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GOT2—alcohol dependence	3.39e-05	0.00037	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2E1—alcohol dependence	3.19e-05	0.000348	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GGT1—alcohol dependence	2.93e-05	0.000319	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GOT1—alcohol dependence	2.93e-05	0.000319	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MAOA—alcohol dependence	2.63e-05	0.000286	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—POMC—alcohol dependence	1.71e-05	0.000186	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—EP300—alcohol dependence	1.13e-05	0.000124	CbGpPWpGaD
